Abstract
Tc-99m-tetrofosmin SPECT was performed on 6 occasions in 4 patients with hypopharyngeal carcinoma, lung carcinoma, esophageal carcinoma and maxillary plasmocytoma and compared with Tl-201 SPECT. All lesions accumulated both Tc-99m-tetrofosmin and Tl-201. Early uptake ratios of Tc-99m-tetrofosmin were about 2 but those of Tl-201 were much higher (more than 3). Washout rates of Tc-99m-tetrofosmin were higher than those of Tl-201. There was a good positive correlation between the early uptake ratio of Tc-99m-tetrofosmin and that of Tl-201. The delayed uptake ratio and washout rate showed poor correlation. In conclusion, early uptakes of both the agents were similar but their retention patterns were different. Tc-99m-tetrofosmin may be used for tumor imaging though more studies are required to evaluate diagnostic accuracy and the significance of delayed images.
This is a preview of subscription content, log in via an institution to check access.
References
Kelly JD, Forster AM, Higley B, Archer CM, Booker FS, Canning LR, et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging.J Nucl Med 34: 222–227, 1993.
Jain D, Wackers FJT, Mattera J, McMahon M, Sinusus AJ, Zaret BL. Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion agent: implication for one-day protocol.J Nucl Med 34: 1254–1259, 1993.
Rigo P, Leclercq B, Itti R, Lahiri A, Braat S. Technetium- 99m-tetrofosmin myocardial imaging: a comparison with thallium-201 and angiography.J Nucl Med 35: 587–593, 1994.
Aktolun C, Bayhan H, Kir M. Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors. Preliminary results and comparison with Tl-201.Clin Nucl Med 17: 171–176, 1992.
Waxman AD, Ramanna L, Memsic LD, Forster CE, Silberman AW, Gleischman SH, et al. Thallium scintigraphy in the evaluation of mass abnormality of the breast.J Nucl Med 34: 18–23, 1993.
O’Tauma LA, Treves ST, Larar JN, Packard AB, Kwan AJ, Barnes PD, et al. Thallium-201 versus technetium-99m- MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison.J Nucl Med 34: 1045–1051, 1993.
Arbab AS, Koizumi K, Araki T. Comparison of uptake mechanisms of Tc-99m-tetrofosmin, Tc-99m-MIBI and Tl-201 in tumor cell lines.KAKU IGAKU (Jpn J Nucl Med) 32: 892, 1995 (abstract).
Maublant J, Veyre A, Platts EA, Pickett RD. Uptake of Tc-99m-tetrofosmin in isolated mitochondria: evidence for an active mechanism. 35: 46–47, 1994 (abstract).
Basoglu T, Sahin M, Coskun C, Koparan A, Bernay I, Erkan L. Technetium-99m-tetrofosmin uptake in malignant lung tumors.Eur J Nucl Med 22: 687–689, 1995.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arbab, A.S., Koizumi, K., Arai, T. et al. Application of Tc-99m-tetrofosmin as a tumor imaging agent: Comparison with Tl-201. Ann Nucl Med 10, 271–274 (1996). https://doi.org/10.1007/BF03165405
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03165405